Qiming Corporate GP VI, Ltd. sold ALMR

October 19, 2026 · Form 4 insider transaction

Qiming Corporate GP VI, Ltd. sold 11,443 shares of Alamar Biosciences, Inc. at $26.34 per share, a transaction worth $301.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
11,443
Price
$26.34
Total value
$301.4K
Role10% owner
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 19, 2026
Filing dateOctober 21, 2026
Shares owned after1,567,881
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2 to $26.52, inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1) through (4) to this Form 4.; These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.

View the original Form 4 on SEC EDGAR